LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Enliven Therapeutics (NASDAQ: ELVN)

Follow NASDAQ:ELVN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
05/27/2025
Sell
$2.48
3,250
$8K
122,056
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
05/27/2025
Buy
$2.48
3,250
$8K
26,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
05/27/2025
Sell
$16.18
3,250
$53K
23,000
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
05/19/2025
Sell
$16.31
5,000
$82K
985,188
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
05/19/2025
Sell
$16.49
5,000
$82K
972,892
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
05/07/2025
Sell
$18.30
6,173
$113K
310,470
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
05/07/2025
Sell
$19.40
390
$8K
310,080
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
05/07/2025
Sell
$19.87
104
$2K
309,976
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
05/01/2025
Sell
$20.07
5,030
$101K
992,658
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
05/02/2025
Sell
$20.01
2,470
$49K
990,188
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
05/01/2025
Sell
$20.08
5,330
$107K
980,062
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
05/02/2025
Sell
$20.00
2,170
$43K
977,892
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
04/28/2025
Sell
$2.48
3,250
$8K
125,306
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
04/28/2025
Buy
$2.48
3,250
$8K
26,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
04/28/2025
Sell
$18.68
3,181
$59K
23,069
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
04/28/2025
Sell
$19.12
69
$1K
23,000
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
04/21/2025
Sell
$16.03
4,670
$75K
998,018
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
04/21/2025
Sell
$16.72
330
$6K
997,688
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
04/17/2025
Sell
$16.42
5,000
$82K
985,392
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
04/07/2025
Sell
$17.81
3,756
$67K
319,554
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
04/07/2025
Sell
$18.29
2,763
$51K
316,791
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
04/07/2025
Sell
$19.27
148
$3K
316,643

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous